| Dendrimers as drug carriers: applications in different routes of drug administration Y Cheng, Z Xu, M Ma, T Xu Journal of pharmaceutical sciences 97 (1), 123-143, 2008 | 606 | 2008 |
| Polymer-Coated NaYF4:Yb3+, Er3+ Upconversion Nanoparticles for Charge-Dependent Cellular Imaging J Jin, YJ Gu, CWY Man, J Cheng, Z Xu, Y Zhang, H Wang, VHY Lee, ... ACS nano 5 (10), 7838-7847, 2011 | 307 | 2011 |
| Polyamidoamine (PAMAM) dendrimers as biocompatible carriers of quinolone antimicrobials: an in vitro study Y Cheng, H Qu, M Ma, Z Xu, P Xu, Y Fang, T Xu European journal of medicinal chemistry 42 (7), 1032-1038, 2007 | 250 | 2007 |
| Evaluation of polyamidoamine (PAMAM) dendrimers as drug carriers of anti-bacterial drugs using sulfamethoxazole (SMZ) as a model drug M Ma, Y Cheng, Z Xu, P Xu, H Qu, Y Fang, T Xu, L Wen European journal of medicinal chemistry 42 (1), 93-98, 2007 | 241 | 2007 |
| MYC protein inhibits transcription of the microRNA cluster MC-let-7a-1∼ let-7d via noncanonical E-box Z Wang, S Lin, JJ Li, Z Xu, H Yao, X Zhu, D Xie, Z Shen, J Sze, K Li, G Lu, ... Journal of Biological Chemistry 286 (46), 39703-39714, 2011 | 96 | 2011 |
| miR-216b regulation of c-jun mediated gadd153/chop-dependent apoptosis Z Xu, Y Bu, N Chinis, C Koumenis, SY Fuchs, JA Diehl Nature Communications, 2016 | 76 | 2016 |
| New insights into molecules and pathways of cancer metabolism and therapeutic implications Z Tang, Z Xu, X Zhu, J Zhang Cancer Communications 41 (1), 16-36, 2021 | 70 | 2021 |
| Upconversion Nanoparticles Conjugated with Gd3+‐DOTA and RGD for Targeted Dual‐Modality Imaging of Brain Tumor Xenografts J Jin, Z Xu, Y Zhang, YJ Gu, MHW Lam, WT Wong Advanced healthcare materials 2 (11), 1501-1512, 2013 | 68 | 2013 |
| MYC Drives Group 3 Medulloblastoma through Transformation of Sox2+ Astrocyte Progenitor Cells. P Ran Tao, Najiba Murad, Zhenhua Xu Cancer Research 79 (8), 2019 | 40 | 2019 |
| Elevated chemokine CC-motif receptor-like 2 (CCRL2) promotes cell migration and invasion in glioblastoma F Yin, Z Xu, Z Wang, H Yao, Z Shen, F Yu, Y Tang, D Fu, S Lin, G Lu, ... Biochemical and biophysical research communications 429 (3-4), 168-172, 2012 | 32 | 2012 |
| Transcriptional regulation in model organisms: recent progress and clinical implications J Tang, Z Xu, L Huang, H Luo, X Zhu Open Biology 9 (11), 190183, 2019 | 24 | 2019 |
| Folic acid conjugated mPEG-PEI600 as an efficient non-viral vector for targeted nucleic acid delivery Z Xu, J Jin, LKS Siu, H Yao, J Sze, H Sun, H Kung, WS Poon, SSM Ng, ... International journal of pharmaceutics 426 (1-2), 182-192, 2012 | 22 | 2012 |
| Colorimetric determination of polyamidoamine dendrimers and their derivates using a simple and rapid ninhydrin assay Z Xu, T Xu, Y Cheng, M Ma, P Xu, H Qu, L Wen Analytical letters 41 (3), 444-455, 2008 | 12 | 2008 |
| Evaluation of polyamidoamine (PAMAM) dendrimers as drug carriers of anti2bacterial drugs using sulfamethoxazole (SMZ) as a model drug M Minglu, C Yiyun, X Zhenhua European Journal of Medicinal Chemistry 42, 93-98, 2007 | 12 | 2007 |
| Loss of MYC and E-box3 binding contributes to defective MYC-mediated transcriptional suppression of human MC-let-7a-1~ let-7d in glioblastoma Z Wang, S Lin, J Zhang, Z Xu, Y Xiang, H Yao, L Ge, D Xie, H Kung, G Lu, ... Oncotarget 7 (35), 56266, 2016 | 8 | 2016 |
| OLIG2 Is a Determinant for the Relapse of MYC-Amplified Medulloblastoma Z Xu, N Murad, D Malawsky, R Tao, S Rivero-Hinojosa, D Holdhof, ... Clinical Cancer Research 28 (19), 4278-4291, 2022 | 6 | 2022 |
| The 3′ UTR Variants in the GRP78 Are Not Associated with Overall Survival in Resectable Hepatocellular Carcinoma X Zhu, F Wang, MCM Lin, L Tian, W Fan, SS Ng, M Liu, J Huang, Z Xu, ... PLoS One 6 (3), e17783, 2011 | 4 | 2011 |
| Epigenetics in cancer: mechanisms and drug development-volume II X Zhu, Z Xu, B Li Frontiers in Genetics 14, 1242960, 2023 | 1 | 2023 |
| Background: MicroRNAs (miRNAs) and long non-coding RNAs (lncRNAs) play vital regulatory roles in pancreatic cancer (PC) initiation and progression. We aimed to explore the … Z Xu, D Zhang, Z Zhang, W Luo, R Shi, J Yao, D Li, L Wang, B Liao Epigenetics in Cancer: Mechanisms and Drug Development, 2022 | | 2022 |
| Epigenetics in Cancer: Mechanisms and Drug Development H Yuan, Y Huang, S Tao, B Li, Z Xu, Y Qi, B Wu, H Luo, X Zhu Frontiers in Genetics 13, 831704, 2022 | | 2022 |
Xiao ZhuGuangdong Medical UniversityAdresse e-mail validée de gdmu.edu.cn
